Patient info Open main menu

Ceanel Concentrate – Summary of Product Characteristics (SmPC) for healthcare professionals

Last updated: · Text from the MHRA, as of · About this document

The Summary of Product Characteristics (SmPC) is written for healthcare professionals. Patients will find plain advice in the patient information leaflet.

Contains active substances:
ATC code:

Summary of Product Characteristics (SmPC) - Ceanel concentrate

1 NAME OF THE MEDICINAL PRODUCT

Ceanel Concentrate

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Cetrimide 10.0% w/v

Undecenoic Acid 1.0% v/v

For full list of excipients, see section 6.1

3 PHARMACEUTICAL FORM

Shampoo

Clear, viscous, golden-yellow coloured liquid.

4 CLINICAL PARTICULARS

4.1 Therapeutic indications

As an adjunct in the management psoriasis of the scalp, seborrhoeic dermatitis, dandruff, psoriasis of the trunk and limbs.

4.2 Posology and method of administration

For topical use only.

Adults, Children and the Elderly:

Scalp Conditions

Wet the scalp and hair with warm water. Protect the eyes with a towel to avoid discomfort. Apply 1/2 -1 teaspoonful of Ceanel to the wetted scalp. Then apply a small amount of water and work up into a lather. Rinse and repeat. Finally rinse the hair and scalp thoroughly. Use three times in the first week and twice weekly thereafter.

Other areas of the body.

Wet the area to be treated with warm water; apply sufficient Ceanel Concentrate by gentle massage to cover the wetted area. Allow to remain in contact for two minutes. Remove the Ceanel by thorough rinsing with warm water. Use as required.

4.3 Contraindications

Hypersensitivity to the active substances or to any of the excipients listed in section 6.1

4.4 Special warnings and precautions for use

In common with other shampoos, it is suggested that the eyes be closed during treatment to avoid discomfort or that they may be protected with a towel.

4.5 Interaction with other medicinal products and other forms of interaction

No interaction studies have been performed.

4.6 Fertility, pregnancy and lactation

There is inadequate evidence of safety in human pregnancy, but it has been in wide use for many years without apparent ill consequence. As with other medicaments it may be used during pregnancy if the anticipated benefits outweigh the risks. No problems are anticipated during lactation.

4.7 Effects on ability to drive and use machines

Not applicable.

4.8 Undesirable effects

Skin irritation may occasionally occur and hypersensitivity reactions may develop in certain individuals.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

4.9 Overdose

Following accidental ingestion, nausea and vomiting may occur as well as respiratory problems and hypotension. Treatment is supportive and symptomatic avoiding gastric lavage

5 PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

Pharmacotherapeutic group: Other dermatological preparations, medicated shampoos

ATC Code: D11AC

Cetrimide is particularly active against Gram-positive organisms. This feature combined with the fungicidal properties of undecenoic acid makes Ceanel Concentrate particularly effective in the treatment of dermatological conditions, Ceanel Concentrate is effective in removing debris and scale in seborrhoea capitis and psoriasis of the scalp.

5.2 Pharmacokinetic properties

Not applicable.

5.3 Preclinical safety data

None stated.

6 PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Phenylethyl Alcohol,

Poly Oxy Propylene Stearyl Ether,

`Purified Water BP.

Ninol CDX:

N,N-Bis(hydroxyethyl)octanamide

Diethanolamine

Lauric acid

6.2 Incompatibilities

None known

6.3 Shelf life

3 years

6.4 Special precautions for storage

Do not store above 25°C

6.5 Nature and contents of container

Ceanel Concentrate is available in polyethylene bottles with a screw top.

Pack sizes: 150ml and 500ml. Not all pack sizes may be marketed.

6.6 Special precautions for disposal

Any unused medicinal product or waste material should be disposed of in accordance with local requirements.

7 MARKETING AUTHORISATION HOLDER

Derma UK Ltd

The Toffee Factory

Lower Steenbergs Yard, Quayside

Ouseburn, Walker Rd

Newcastle upon Tyne

Tyne and Wear NE1 2DF

UK

8 MARKETING AUTHORISATION NUMBER(S)

PL 19876/0015

9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

1 January 2004

10 DATE OF REVISION OF THE TEXT

23/03/2021

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 19876/0015

Last revision stated in the text: 23 March 2021 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Ceanel concentrate

Active substances Phenylethyl alcohol, Undecenoic acid, Cetrimide
Pharmaceutical form Clear, viscous, golden-yellow coloured liquid.
Excipients Phenylethyl Alcohol,, Poly Oxy Propylene Stearyl Ether,, `Purified Water BP., N,N-Bis(hydroxyethyl)octanamide, Diethanolamine, Lauric acid
Shelf life 3 years
Storage Do not store above 25°C
Drug group (ATC) Other dermatological preparations, medicated shampoos
  1. D Dermatologicals
    1. D11 Other dermatological preparations
      1. D11A Other dermatological preparations
        1. D11AC Medicated shampoos
          1. D11AC01 cetrimide
Marketing authorisation PL 19876/0015 (first authorised 1 January 2004)
Marketing authorisation holder Derma UK Ltd

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.